rs20539
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000611820.5(KDM6A):c.3267G>A(p.Gln1089=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.198 in 1,189,505 control chromosomes in the GnomAD database, including 18,401 homozygotes. There are 76,408 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 1620 hom., 5527 hem., cov: 22)
Exomes 𝑓: 0.20 ( 16781 hom. 70881 hem. )
Consequence
KDM6A
ENST00000611820.5 synonymous
ENST00000611820.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.88
Genes affected
KDM6A (HGNC:12637): (lysine demethylase 6A) This gene is located on the X chromosome and is the corresponding locus to a Y-linked gene which encodes a tetratricopeptide repeat (TPR) protein. The encoded protein of this gene contains a JmjC-domain and catalyzes the demethylation of tri/dimethylated histone H3. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-45079318-G-A is Benign according to our data. Variant chrX-45079318-G-A is described in ClinVar as [Benign]. Clinvar id is 158689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-45079318-G-A is described in Lovd as [Likely_benign]. Variant chrX-45079318-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.88 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM6A | NM_001291415.2 | c.3267G>A | p.Gln1089= | synonymous_variant | 21/30 | ENST00000611820.5 | NP_001278344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM6A | ENST00000611820.5 | c.3267G>A | p.Gln1089= | synonymous_variant | 21/30 | 1 | NM_001291415.2 | ENSP00000483595 | P4 |
Frequencies
GnomAD3 genomes AF: 0.169 AC: 18636AN: 110287Hom.: 1626 Cov.: 22 AF XY: 0.170 AC XY: 5522AN XY: 32543
GnomAD3 genomes
AF:
AC:
18636
AN:
110287
Hom.:
Cov.:
22
AF XY:
AC XY:
5522
AN XY:
32543
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.252 AC: 46012AN: 182718Hom.: 5160 AF XY: 0.242 AC XY: 16291AN XY: 67236
GnomAD3 exomes
AF:
AC:
46012
AN:
182718
Hom.:
AF XY:
AC XY:
16291
AN XY:
67236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.200 AC: 216359AN: 1079163Hom.: 16781 Cov.: 28 AF XY: 0.204 AC XY: 70881AN XY: 347453
GnomAD4 exome
AF:
AC:
216359
AN:
1079163
Hom.:
Cov.:
28
AF XY:
AC XY:
70881
AN XY:
347453
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.169 AC: 18620AN: 110342Hom.: 1620 Cov.: 22 AF XY: 0.170 AC XY: 5527AN XY: 32606
GnomAD4 genome
AF:
AC:
18620
AN:
110342
Hom.:
Cov.:
22
AF XY:
AC XY:
5527
AN XY:
32606
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:6
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied by a panel of primary immunodeficiencies. Number of patients: 43. Only high quality variants are reported. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 01, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 22, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2018 | - - |
Kabuki syndrome 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at